The straight answer
Let's be straight with you: no peptide is a proven treatment for concussion or traumatic brain injury. The honest state of things is that most brains recover from a concussion on their own with time and the right kind of rest, and there is no shot or nasal spray you can take to speed that up in a way that's been proven in solid human trials. One compound in our library, Cerebrolysin, has actually been tested in TBI patients and is used for this in some countries, but even its evidence is mixed and it is not approved in the US. Everything else here is either studied only for stroke, or only in animals, or not really studied for brain injury at all.
What actually treats it
The real treatment is time plus a smart, staged return to activity: 24 to 48 hours of relative rest, then a gradual, doctor-guided step-up in mental and physical activity as long as symptoms don't flare, with treatment for specific problems like headaches, sleep, dizziness, or mood. A doctor or concussion clinic guides this, and any warning signs (worsening headache, repeated vomiting, confusion, weakness) mean urgent care right away.
From our library
Compounds here with any tie to concussion & tbi — rated honestly for this specific use.
- Emerging
Cerebrolysin
Worth a lookThis is the only compound in our library with real human trial data specifically in traumatic brain injury. The CAPTAIN trial series (two placebo-controlled trials) found a small but statistically significant improvement in recovery scores after moderate-to-severe TBI. That said, it is an IV drug given in a hospital, it is not FDA-approved, the broader evidence is mixed, and it has never been shown to work for everyday concussions. Interesting, not a proven fix, and only ever under a doctor's care.
- Early
Semax
SpeculativeSemax is a prescription brain-recovery drug in Russia, but its human evidence is for stroke, not head injury, and even that comes from small studies. The idea that it helps a concussion is a reasonable extrapolation from animal work showing it raises the brain's own repair signals and calms inflammation after injury, but nobody has actually tested it in concussion or TBI patients. Promising biology, no real proof for this condition.
- Early
Adamax
Not reallyAdamax is a chemically tweaked, longer-lasting version of Semax sold online. Almost none of the published research is actually on this modified version, and one lab test found it protected brain cells worse than plain Semax. There is no human brain-injury evidence for it at all. We list it only because it gets marketed for brain recovery, not because it's earned a place there.
- Early
Dihexa
Not reallyDihexa mimics a brain growth factor and has repaired memory problems in mice and rats, which is why it gets talked about for brain repair. But it has never been tested in a single human study, for TBI or anything else, and it's sold as an unregulated research chemical. The tie to concussion is a theory built on rodents, nothing more.
Also being studied (not in our library)
- CAQK — A tiny four-amino-acid peptide that homes in on injured brain tissue and, in animal models of TBI, reduced inflammation and cell death. Researchers have said they hope to seek FDA permission for first human trials, so it is still purely preclinical.
- GLP-1 drugs (incretins, e.g. exenatide, liraglutide) — The same gut-hormone drugs used for diabetes and weight loss are being studied as brain-protectants after TBI, based mostly on cell and animal work plus a few small human studies. Genuinely interesting research direction, but not a proven TBI treatment, and well-designed trials are still needed.
- Nerinetide (NA-1) — A neuroprotective peptide tested in large human trials for acute stroke with mixed results. It targets the same kind of brain-cell injury cascade seen after trauma, but it is investigational and not established for TBI.
Bottom line
No peptide is a proven treatment for concussion or TBI, and anyone selling one as a cure for your brain injury is overselling thin evidence. Cerebrolysin is the only one here with real TBI trial data, and even that is mixed, hospital-administered, and not approved in the US.